Talk:Shunthi: Difference between revisions

(One intermediate revision by one other user not shown)

Line 6:

|label2 = Botanical name(s)

|data2 = Zingiber officinale Roscoe

|label3 = ~~Contributors~~

|label3 = Family

|data3 = --

|data3 = Zingiberaceae

|label4 = Year of publication

|label4 = Availability

|~~data4~~ = ~~2024~~

|data4 = Available

|~~label5~~ = Publisher

|label5 = Contributors

|~~data5~~ = [[Charak Samhita Research, Training and Skill Development Centre]]

|data5 = Dravyaguna Team

|~~label6~~ = DOI

|label6 = Year of publication

|~~data6~~ = Awaited

|data6 = 2026

|label7 = Publisher

|data7 = [[Charak Samhita Research, Training and Skill Development Centre]]

|label8 = DOI

|data8 = Awaited

}}

Line 19:

Line 23:

Ginger

== Botanical Identity ==

'''Shunthi''', the dried rhizome of ''Zingiber officinale'' Roscoe (Family: '''Zingiberaceae'''), stands as a cornerstone phytopharmaceutical in traditional systems of medicine—particularly Ayurveda—while simultaneously maintaining a robust profile in modern evidence-based pharmacology. Locally referred to as ''Sonth'' or dry ginger, its processing from fresh ginger (''Ardraka'') chemically transforms its active volatile and non-volatile profiles, resulting in a distinct therapeutic matrix that exhibits high bioavailability and pronounced efficacy across multiple physiological systems.

* '''Botanical Name:''' ''Zingiber officinale'' Roscoe

* '''Family:''' Zingiberaceae

* '''Part Used:''' Dried Rhizome

* '''Vernacular Names:''' Shunthi (Sanskrit), Sonth (Hindi), Dry Ginger (English), Shukku (Tamil)

== Ayurvedic Pharmacodynamics (Dravyaguna Profile) ==

In classical Ayurvedic pharmacology, the dehydration of ginger alters its fundamental properties. Unlike fresh ginger, which carries a sharp, drying post-digestive profile, Shunthi undergoes a metabolic transformation that yields a sweet post-digestive effect (''Madhura Vipaka''), rendering it far more tolerable for long-term therapeutic application without aggravating ''Pitta dosha'' excessively.

==Therapeutic Use==

Agnimandya, Bronchial asthma (swasa), Abdominal distension (adhmana), Rheumatoid arthritis (amavata), Anaemia (pandu), Abdominal disorders (udararoga)

==Varieties==

==Bhavaprakash Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, p.13.</ref>==

# Raktabha

# Shweta

== Synonyms in Charak Samhita==

Shunthi, Nagara, Shrungavera, Vishwa-bheshajam, Mahaushadha, Ardraka, Vishwa.

==Synonyms in Bhavaprakasha Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, verse no. 44, p.13.</ref>==

Shunthi, Vishva, Vishv, Nagar, Vishvabheshaja, Ushana, Katubhadra, Shringavera, Mahoshadha,

== Ayurvedic pharmacological properties ==

{| class="wikitable"

|+ Properties

|-

! Sr.no. !! Pharmacological criteria !! Properties !! Clinical Significance

|-

| 1 || Taste ([[rasa]]) || Pungent (katu) || Stimulates gustatory receptors, secretes salivary and gastric enzymes.

|-

| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])

|-

| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura) || Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.

|-

| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna) || Counteracts the coldness of ''Kapha''.

|-

| 5 || Actions ([[karma]]) || Pacify Vata and Kapha

|-

| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.

|}

== Reference in Charak Samhita and its actions ==

Line 31:

Line 83:

|-

| 1 ||Cha.Sa.[[Sutra Sthana]] 2/5

| ~~Sirovirechana~~ (Errhine therapy)

| Shirovirechana (Errhine therapy)

|-

| 2 ||Cha.Sa.[[Sutra Sthana]] 2/18

| Deepaniya and Shulaghni yavagu

| Deepaniya and Shulaghni yavagu(gruel for enhancing digestion and colic pain)

|-

| 3 ||Cha.Sa.[[Sutra Sthana]] 2/21

| Raktatisara yavagu

| Raktatisara yavagu(gruel used in diarrhea with blood)

|-

| 4 ||Cha.Sa.[[Sutra Sthana]] 2/22

| Amatisara yavagu

| Amatisara yavagu(gruel for diarrhea with indigestion)

|-

| 5 ||Cha.Sa.[[Sutra Sthana]] 2/24

| Pipasaghni yavagu

| Pipasaghni yavagu(gruel for excess thirst)

|-

|6

|Cha.Sa.[[Sutra Sthana]] 4/9(6)

|Deepaniya ~~mahakashay~~

|Deepaniya (appetizer) mahakashaya

|-

|7

|Cha.Sa.[[Sutra Sthana]] 4/9(11)

|Truptighna ~~mahakashay~~

|Truptighna(anti-satiety) mahakashaya

|-

|8

|Cha.Sa.[[Sutra Sthana]] 4/9(12)

|Arshoghna ~~mahakashay~~

|Arshoghna(anti-haemorrhoidal) mahakashaya

|-

|9

|Cha.Sa.[[Sutra Sthana]] 4/9(18)

|Stanyashodhana ~~mahakashay~~

|Stanyashodhana(galactodepurent) mahakashaya

|-

|10

|Cha.Sa.[[Sutra Sthana]] 4/9(29)

|Trishna nigrahana mahakashay

|Trishna nigrahana(thirst alleviating) mahakashay

|-

|11

|Cha.Sa.[[Sutra Sthana]] 4/9(42)

|Sheetaprashamana mahakashaya

|Sheetaprashamana(pacifying cold sensation) mahakashaya

|-

|12

|Cha.Sa.[[Sutra Sthana]] 4/9(45)

|Shoolaprashamana mahakashaya

|Shoolaprashamana(pacifying pain) mahakashaya

|-

|13

|Cha.Sa.[[Sutra Sthana]]24/49

|Sanyas Chikitsa

|Sanyas Chikitsa- to regain consciousness

|-

|14

|Cha.Sa.[[Sutra Sthana]] 25/38

|Hitatam ahardravya

|Hitatam ahardravya(wholesome food articles) -ginger among all rhizomes and roots.

|-

|15

|Cha.Sa.[[Sutra Sthana]] 27/4

|~~Natural qualities~~.

|All substances with pungent taste, except long pepper and ginger, are vata stimulants and aphrodisiacs.

|-

|16

|Cha.Sa.[[Sutra Sthana]] 27/166

|Harita Varga

|One of the drug from Harita Varga (green herbs)

|-

|17

|Cha.Sa.[[Sutra Sthana]] 27/166

|Harita Varga

|One of the drug from Harita Varga (green herbs)

|-

|18

|Cha.Sa.[[Sutra Sthana]] 27/256

|Krutanna Varga

|One of the drug from Krutanna Varga (cooked food preparations)

|-

|19

|Cha.Sa.[[Sutra Sthana]] 27/296

|Krutanna Varga

|One of the drug from Krutanna Varga (cooked food preparations)

|-

|20

|Cha.Sa.[[Sutra Sthana]] 26/51

|~~Rasapvad~~

|Rasapvada (exception in pungent (katu) rasa.

|-

|21

|Cha.Sa.[[Vimana Sthana]] 6/17

|Abhyantar Krimi Chikitsa

|Abhyantar Krimi Chikitsa (treatment of internal worms).

|-

|22

|Cha.Sa.[[Vimana Sthana]] 6/18

|Abhyantar Krimi Chikitsa

|Abhyantar Krimi Chikitsa (treatment of internal worms).

|-

|23

|Cha.Sa.[[Vimana Sthana]] 8/135

|Vaman dravyani

|Vaman dravyani (As a drug for therapeutic emesis)

|-

|24

|Cha.Sa.[[Vimana Sthana]] 8/142

|Katuskandha

|Katuskandha (group of pungent drugs)

|-

|25

|Cha.Sa.[[Sharira Sthana]] 8/56

|Kshira vishodhan dravya

|Kshira vishodhan dravya (ingredient of galactodepurant gana)

|-

|26

Line 139:

Line 191:

|29

|Cha.Sa.[[Kalpa Sthana]] 1/22

|Vamanartha

|Vamanartha (for therapeutic emesis)

|-

|30

Line 164:

Line 216:

|Cha.Sa.[[Chikitsa Sthana]] 3/145

|When patient is suffering with ~~Pipasa~~ in ~~jwara~~ as an ingredient of Shadangapaniya.

|When patient is suffering with thirst (pipasa) in fever (Jwara) as an ingredient of Shadangapaniya.

Used as shrutasheetajala as it is Pipasajwarshantaye.

Line 170:

Line 223:

|36

|Cha.Sa.[[Chikitsa Sthana]] 3/179

|Used as lajapeya with Pippali where agnimandya but kshudha is present.

|-

Line 183:

Line 235:

|39

|Cha.Sa.[[Chikitsa Sthana]] 3/186

|Used as peya where jwara is associated with Constipation & Kostha shoola.

|Used as peya where jwara(fever) is associated with Constipation(vibandha) & Kostha shoola.

|-

|40

|Cha.Sa.[[Chikitsa Sthana]] 3/188

|Used as peya with Ghrita and Sarkara where jwara is associated with Anindra, Trushna & asweda.

|Used as peya with Ghrita and Sarkara where jwara is associated with Anindra(insomia), Trushna(thirst) & asweda.

|-

|41

Line 1,119:

Line 1,171:

|}

== Ayurvedic ~~pharmacological properties~~ ==

==Dose<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==

* Churna – 1 – 2 gm

~~{| class~~=~~"wikitable"~~

==Important formulations<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==

~~|+ Properties~~

|-

~~! Sr~~.no. ~~!! Pharmacological criteria !! Properties~~

|-

~~| 1 || Taste ([[rasa]]) || Pungent (katu)~~

|-

~~| 2 || Potency ([[veerya]]) ||Hot (ushna)~~

|-

~~| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura)~~

|-

~~| 4 || Qualities ([[guna]])|| Heavy (guru)~~, ~~Rough (ruksha)~~, ~~Sharp (tikshna)~~

|-

~~| 5 || Actions ([[karma]]) || Pacify Vata and Kapha~~

|-

|}

* Saubhagya Shunthi

* Saubhagya Vati

* Trikatu Churna

* Vaishvanara Churna

== Current availability==

Available

* In India –

Kerala, Assam, Meghalaya, Arunachal Pradesh, Mizoram, Karnataka, Odisha, West bengal

* Out of India –

China, Nigeria, Indonesia, Thailand, Jamaica, Bangladesh, Ethiopia, Nepal, Vietnam, Philippines

== Current researches ==

== Phytochemical Architecture ==

The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils:

* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.

* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.

* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.

* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.

== Modern Pharmacological Validation & Therapeutic Efficacy ==

=== A. Gastrointestinal Efficacy (Deepana, Pachana, & Anulomana) ===

Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.

* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT3 receptors''' and cholinergic M3 receptors in the gastrointestinal tract.

* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.

=== B. Anti-Inflammatory & Analgesic Efficacy (Amavataghni) ===

In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.

: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE2) and leukotrienes.

Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.

=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===

Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems:

* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca2+) channel-blocking activity, shifting Ca2+ dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.

* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.

* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.

<pre>

[6]-Shogaol / [6]-Gingerol (Active Constituents)

│

┌────────────────┴────────────────┐

▼ ▼

Inhibition of NF-κB Ca²⁺ Channel Blockade

│ │

▼ ▼

↓ COX-2 & LOX Pathways Vasodilation of

(↓ CRP, ↓ TNF-α, ↓ PGE₂) Vascular Smooth Muscle

│ │

▼ ▼

Clinical: Alleviation of Clinical: Reduction of

Arthritis & Joint Pain Systemic Blood Pressure

</pre>

== Clinical Safety, Dosage, and Contraindications ==

Shunthi enjoys a wide therapeutic index and is designated as '''GRAS''' (Generally Recognized as Safe) by global regulatory bodies. However, its high thermal potency warrants structured clinical application.

* '''Standard Therapeutic Dosage:'''

** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.

** ''Extract:'' 250 - 500 mg two to three times daily.

* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.

* '''Drug Interactions:''' Due to its mild anti-platelet and calcium-channel-blocking properties, cautious monitoring is recommended when co-administered with high-dose synthetic anticoagulants (e.g., Warfarin) or prescription antihypertensives.

* '''Contraindications:''' Acute peptic ulceration, active GI bleeding, and inflammatory dermatological conditions characterized by extreme ''Pitta'' vitiation.

== References ==

# '''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.

# '''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.

# '''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.

# '''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.

# '''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.

# '''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.

[[Category: Database of herbs and minerals | Herbs]]

~~This article is under development ..~~

@@ Line 6: / Line 6: @@
 |label2 = Botanical name(s)
 |data2 = Zingiber officinale Roscoe
-|label3 = Contributors
+|label3 = Family
-|data3 = --
+|data3 = Zingiberaceae
-|label4 = Year of publication
+|label4 = Availability
-|data4 =  2024
+|data4 = Available
-|label5 = Publisher
+|label5 = Contributors
-|data5 =  [[Charak Samhita Research, Training and Skill Development Centre]]
+|data5 = Dravyaguna Team
-|label6 = DOI
+|label6 = Year of publication
-|data6  = Awaited
+|data6 =  2026
+|label7 = Publisher
+|data7 =  [[Charak Samhita Research, Training and Skill Development Centre]]
+|label8 = DOI
+|data8  = Awaited
 }}
@@ Line 19: / Line 23: @@
 Ginger
+== Botanical Identity ==
+'''Shunthi''', the dried rhizome of ''Zingiber officinale'' Roscoe (Family: '''Zingiberaceae'''), stands as a cornerstone phytopharmaceutical in traditional systems of medicine—particularly Ayurveda—while simultaneously maintaining a robust profile in modern evidence-based pharmacology. Locally referred to as ''Sonth'' or dry ginger, its processing from fresh ginger (''Ardraka'') chemically transforms its active volatile and non-volatile profiles, resulting in a distinct therapeutic matrix that exhibits high bioavailability and pronounced efficacy across multiple physiological systems.
+* '''Botanical Name:''' ''Zingiber officinale'' Roscoe
+* '''Family:''' Zingiberaceae
+* '''Part Used:''' Dried Rhizome
+* '''Vernacular Names:''' Shunthi (Sanskrit), Sonth (Hindi), Dry Ginger (English), Shukku (Tamil)
+== Ayurvedic Pharmacodynamics (Dravyaguna Profile) ==
+In classical Ayurvedic pharmacology, the dehydration of ginger alters its fundamental properties. Unlike fresh ginger, which carries a sharp, drying post-digestive profile, Shunthi undergoes a metabolic transformation that yields a sweet post-digestive effect (''Madhura Vipaka''), rendering it far more tolerable for long-term therapeutic application without aggravating ''Pitta dosha'' excessively.
+==Therapeutic Use==
+Agnimandya, Bronchial asthma (swasa), Abdominal distension (adhmana), Rheumatoid arthritis (amavata), Anaemia (pandu), Abdominal disorders (udararoga)
+==Varieties==
+==Bhavaprakash Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, p.13.</ref>==
+# Raktabha
+# Shweta
 == Synonyms in Charak Samhita==
 Shunthi, Nagara, Shrungavera, Vishwa-bheshajam, Mahaushadha, Ardraka, Vishwa.
+==Synonyms in Bhavaprakasha Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, verse no. 44, p.13.</ref>==
+Shunthi, Vishva, Vishv, Nagar, Vishvabheshaja, Ushana, Katubhadra, Shringavera, Mahoshadha,
+== Ayurvedic pharmacological properties ==
+{| class="wikitable"
+|+ Properties
+|-
+! Sr.no. !! Pharmacological criteria !! Properties !! Clinical Significance
+|-
+| 1 || Taste ([[rasa]])  || Pungent (katu) || Stimulates gustatory receptors, secretes salivary and gastric enzymes.
+|-
+| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])
+|-
+| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura) || Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.
+|-
+| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna) || Counteracts the coldness of ''Kapha''.
+|-
+| 5 || Actions ([[karma]]) || Pacify Vata and Kapha
+|-
+| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.
+|}
 == Reference in Charak Samhita and its actions ==
@@ Line 31: / Line 83: @@
 |-
 | 1 ||Cha.Sa.[[Sutra Sthana]] 2/5
-| Sirovirechana (Errhine  therapy)
+| Shirovirechana (Errhine  therapy)
 |-
 | 2 ||Cha.Sa.[[Sutra Sthana]] 2/18
-| Deepaniya and  Shulaghni yavagu
+| Deepaniya and  Shulaghni yavagu(gruel for enhancing digestion and colic pain)
 |-
 | 3 ||Cha.Sa.[[Sutra Sthana]] 2/21
-| Raktatisara  yavagu
+| Raktatisara  yavagu(gruel used in diarrhea with blood)
 |-
 | 4 ||Cha.Sa.[[Sutra Sthana]] 2/22
-| Amatisara  yavagu
+| Amatisara  yavagu(gruel for diarrhea with indigestion)
 |-
 | 5 ||Cha.Sa.[[Sutra Sthana]] 2/24
-| Pipasaghni  yavagu
+| Pipasaghni  yavagu(gruel for excess thirst)
 |-
 |6
 |Cha.Sa.[[Sutra Sthana]] 4/9(6)
-|Deepaniya  mahakashay
+|Deepaniya (appetizer) mahakashaya
 |-
 |7
 |Cha.Sa.[[Sutra Sthana]] 4/9(11)
-|Truptighna  mahakashay
+|Truptighna(anti-satiety) mahakashaya
 |-
 |8
 |Cha.Sa.[[Sutra Sthana]] 4/9(12)
-|Arshoghna  mahakashay
+|Arshoghna(anti-haemorrhoidal) mahakashaya
 |-
 |9
 |Cha.Sa.[[Sutra Sthana]] 4/9(18)
-|Stanyashodhana  mahakashay
+|Stanyashodhana(galactodepurent) mahakashaya
 |-
 |10
 |Cha.Sa.[[Sutra Sthana]] 4/9(29)
-|Trishna  nigrahana mahakashay
+|Trishna  nigrahana(thirst alleviating) mahakashay
 |-
 |11
 |Cha.Sa.[[Sutra Sthana]] 4/9(42)
-|Sheetaprashamana mahakashaya
+|Sheetaprashamana(pacifying cold sensation) mahakashaya
 |-
 |12
 |Cha.Sa.[[Sutra Sthana]] 4/9(45)
-|Shoolaprashamana mahakashaya
+|Shoolaprashamana(pacifying pain) mahakashaya
 |-
 |13
 |Cha.Sa.[[Sutra Sthana]]24/49
-|Sanyas Chikitsa
+|Sanyas Chikitsa- to regain consciousness
 |-
 |14
 |Cha.Sa.[[Sutra Sthana]] 25/38
-|Hitatam  ahardravya
+|Hitatam  ahardravya(wholesome food articles) -ginger among all rhizomes and roots.
 |-
 |15
 |Cha.Sa.[[Sutra Sthana]] 27/4
-|Natural  qualities.
+|All substances with pungent taste, except long pepper and ginger, are vata stimulants and aphrodisiacs.
 |-
 |16
 |Cha.Sa.[[Sutra Sthana]] 27/166
-|Harita Varga
+|One of the drug from Harita Varga (green herbs)
 |-
 |17
 |Cha.Sa.[[Sutra Sthana]] 27/166
-|Harita Varga
+|One of the drug from Harita Varga (green herbs)
 |-
 |18
 |Cha.Sa.[[Sutra Sthana]] 27/256
-|Krutanna Varga
+|One of the drug from Krutanna Varga (cooked food preparations)
 |-
 |19
 |Cha.Sa.[[Sutra Sthana]] 27/296
-|Krutanna Varga
+|One of the drug from Krutanna Varga (cooked food preparations)
 |-
 |20
 |Cha.Sa.[[Sutra Sthana]] 26/51
-|Rasapvad
+|Rasapvada (exception in pungent (katu) rasa.
 |-
 |21
 |Cha.Sa.[[Vimana Sthana]] 6/17
-|Abhyantar Krimi  Chikitsa
+|Abhyantar Krimi Chikitsa (treatment of internal worms).
 |-
 |22
 |Cha.Sa.[[Vimana Sthana]] 6/18
-|Abhyantar Krimi  Chikitsa
+|Abhyantar Krimi Chikitsa (treatment of internal worms).
 |-
 |23
 |Cha.Sa.[[Vimana Sthana]] 8/135
-|Vaman dravyani
+|Vaman dravyani (As a drug for therapeutic emesis)
 |-
 |24
 |Cha.Sa.[[Vimana Sthana]] 8/142
-|Katuskandha
+|Katuskandha (group of pungent drugs)
 |-
 |25
 |Cha.Sa.[[Sharira Sthana]] 8/56
-|Kshira vishodhan  dravya
+|Kshira vishodhan dravya (ingredient of galactodepurant gana)
 |-
 |26
@@ Line 139: / Line 191: @@
 |29
 |Cha.Sa.[[Kalpa Sthana]] 1/22
-|Vamanartha
+|Vamanartha (for therapeutic emesis)
 |-
 |30
@@ Line 164: / Line 216: @@
 |Cha.Sa.[[Chikitsa Sthana]] 3/145
-|When patient is suffering with Pipasa in jwara as an  ingredient of Shadangapaniya.
+|When patient is suffering with thirst (pipasa) in fever (Jwara) as an ingredient of Shadangapaniya.
+Used as shrutasheetajala as it is Pipasajwarshantaye.
 Used as shrutasheetajala as it is Pipasajwarshantaye.
@@ Line 170: / Line 223: @@
 |36
 |Cha.Sa.[[Chikitsa Sthana]] 3/179
 |Used as lajapeya with Pippali where agnimandya but  kshudha is present.
 |-
@@ Line 183: / Line 235: @@
 |39
 |Cha.Sa.[[Chikitsa Sthana]] 3/186
-|Used as peya where jwara is associated with  Constipation & Kostha shoola.
+|Used as peya where jwara(fever) is associated with  Constipation(vibandha) & Kostha shoola.
 |-
 |40
 |Cha.Sa.[[Chikitsa Sthana]] 3/188
-|Used as peya with Ghrita and Sarkara where jwara is  associated with Anindra, Trushna & asweda.
+|Used as peya with Ghrita and Sarkara where jwara is  associated with Anindra(insomia), Trushna(thirst) & asweda.
 |-
 |41
@@ Line 1,119: / Line 1,171: @@
 |}
-== Ayurvedic pharmacological properties ==
+==Dose<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==
+* Churna – 1 – 2 gm
-{| class="wikitable"
+==Important formulations<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==
-|+ Properties
-|-
-! Sr.no. !! Pharmacological criteria !! Properties
-|-
-| 1 || Taste ([[rasa]])  || Pungent (katu)
-|-
-| 2 || Potency ([[veerya]]) ||Hot (ushna)
-|-
-| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura)
-|-
-| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna)
-|-
-| 5 || Actions ([[karma]]) || Pacify Vata and Kapha
-|-
-|}
+* Saubhagya Shunthi
+* Saubhagya Vati
+* Trikatu Churna
+* Vaishvanara Churna
 == Current availability==
 Available
+* In India –
+Kerala, Assam, Meghalaya, Arunachal Pradesh, Mizoram, Karnataka, Odisha, West bengal
+* Out of India –
+China, Nigeria, Indonesia, Thailand, Jamaica, Bangladesh, Ethiopia, Nepal, Vietnam, Philippines
 == Current researches ==
+== Phytochemical Architecture ==
+The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils:
+* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.
+* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.
+* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.
+* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.
+== Modern Pharmacological Validation & Therapeutic Efficacy ==
+=== A. Gastrointestinal Efficacy (Deepana, Pachana, & Anulomana) ===
+Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.
+* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT<sub>3</sub> receptors''' and cholinergic M3 receptors in the gastrointestinal tract.
+* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.
+=== B. Anti-Inflammatory & Analgesic Efficacy (Amavataghni) ===
+In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.
+: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE<sub>2</sub>) and leukotrienes.
+Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.
+=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===
+Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems:
+* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca<sup>2+</sup>) channel-blocking activity, shifting Ca<sup>2+</sup> dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.
+* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.
+* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.
+<pre>
+       [6]-Shogaol / [6]-Gingerol (Active Constituents)
+                         │
+        ┌────────────────┴────────────────┐
+        ▼                                 ▼
+Inhibition of NF-κB               Ca²⁺ Channel Blockade
+        │                                 │
+        ▼                                 ▼
+ ↓ COX-2 & LOX Pathways             Vasodilation of
+(↓ CRP, ↓ TNF-α, ↓ PGE₂)         Vascular Smooth Muscle
+        │                                 │
+        ▼                                 ▼
+Clinical: Alleviation of           Clinical: Reduction of
+ Arthritis & Joint Pain            Systemic Blood Pressure
+</pre>
+== Clinical Safety, Dosage, and Contraindications ==
+Shunthi enjoys a wide therapeutic index and is designated as '''GRAS''' (Generally Recognized as Safe) by global regulatory bodies. However, its high thermal potency warrants structured clinical application.
+* '''Standard Therapeutic Dosage:'''
+** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.
+** ''Extract:'' 250 - 500 mg two to three times daily.
+* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.
+* '''Drug Interactions:''' Due to its mild anti-platelet and calcium-channel-blocking properties, cautious monitoring is recommended when co-administered with high-dose synthetic anticoagulants (e.g., Warfarin) or prescription antihypertensives.
+* '''Contraindications:''' Acute peptic ulceration, active GI bleeding, and inflammatory dermatological conditions characterized by extreme ''Pitta'' vitiation.
+== References ==
+# '''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.
+# '''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.
+# '''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.
+# '''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.
+# '''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.
+# '''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.
 [[Category: Database of herbs and minerals | Herbs]]
- This article is under development ..